2025 | MyInVitroAnswer.com

top of page

A silhouette of young man is facing his computer twin. The individual on the left is a biological entity with a visible brain, holding his patient-derived brain organoid. The individual on the right is a circuit board figure in blue, holding a blue sphere. The image symbolizes complementary between a real-world patient and his digital twin.

A silhouette of young man is facing his computer twin. The individual on the left is a biological entity with a visible brain, holding his patient-derived brain organoid. The individual on the right is a circuit board figure in blue, holding a blue sphere. The image symbolizes complementary between a real-world patient and his digital twin.

Digital Human Twins: Transforming the Future of Human Health

Hybrid AI-in vitro platforms

A stylized complex multi-layer shape, representing 3D bioprinted human tissues for biomedical research. At its center, in orange colour, are functional bioprinted pancreatic islets. The use of innovative computer vision and microscopy technology to obtain an adaptive, context-aware printing is symbolized by eyes situated at the periphery of the printed construct.

A stylized complex multi-layer shape, representing 3D bioprinted human tissues for biomedical research. At its center, in orange colour, are functional bioprinted pancreatic islets. The use of innovative computer vision and microscopy technology to obtain an adaptive, context-aware printing is symbolized by eyes situated at the periphery of the printed construct.

Adaptive and context-aware volumetric printing enhances functional relevance of 3D bioprinted human tissues

Human liver sketched in black and white. A purple grid is situated on top of the liver. Each line of the grid represents the chronology of immune-mediated drug-induced liver injury (DILI) - exposure to a drug or a chemical compound, followed by formation of reactive metabolites, innate immune activation, adaptive immune activation, mitochondrial dysfunction, apoptosis, and necrosis.

Human liver sketched in black and white. A purple grid is situated on top of the liver. Each line of the grid represents the chronology of immune-mediated drug-induced liver injury (DILI) - exposure to a drug or a chemical compound, followed by formation of reactive metabolites, innate immune activation, adaptive immune activation, mitochondrial dysfunction, apoptosis, and necrosis.

Immune-competent human liver organoids model adaptive immunity-mediated idiosyncratic DILI

Organoid technologies

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

3D immuno-glial-neurovascular human brain platform for high-fidelity disease modelling

3D tissue platforms

Stylized pink and orange tree with a bubble-like texture, stands against a pastel gradient background. The tree is composed of 6 groups of branches, representing a newly engineered 6 region brain organoid.

Stylized pink and orange tree with a bubble-like texture, stands against a pastel gradient background. The tree is composed of 6 groups of branches, representing a newly engineered 6 region brain organoid.

Multi-region brain organoids for unprecedented insights into human neurodevelopmental disorders

Organoid technologies

Genetic Engineering Unlocks Organotypic Vascularization

Organ-on-a-chip systems

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Intra-industry partnerships

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Prellis Biologics joins forces with Eli Lilly to transform how target-specific human antibodies are generated

Pharma & biotech collaborations

Heartbeat.bio partners with Boehringer Ingelheim to develop gene therapy for cardiomyopathy

Heartbeat.bio partners with Boehringer Ingelheim to develop gene therapy for cardiomyopathy

Heartbeat.bio partners with Boehringer Ingelheim to develop gene therapy for cardiomyopathy

Pharma & biotech collaborations

UMC Utrecht receives €2.3M grant to advance its generative, context-aware 3D bioprinting method

Grants Awarded & Funds Raised

Hesperos awarded Phase IIB SBIR grant to investigate drug-induced cognitive impairment using its Human-on-a-Chip®

Grants Awarded & Funds Raised

Genoskin raises $8.7M to advance immunocompetent human skin models

Grants Awarded & Funds Raised

bottom of page